Recent Press Releases

Catamaran and OptumRx to Combine

Clients and individuals will benefit from enhanced services and cost trend management; combined organization expects to fulfill more than one billion scripts Combining OptumRx's unique medical...

Teva Expands Hypertension Line with Launch of Generic Exforge® Tablets in the United States

JERUSALEM--(BUSINESS WIRE)--Mar. 31, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Exforge® (amlodipine and valsartan) Tablets in four...

Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares POTTERS BAR, England, March 30, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today...

Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

POTTERS BAR, England, March 30, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the underwritten public offering (the "Offering") of 35,000,000 ordinary shares held by certain...

Novartis announces FDA approval for JadenuTM to simplify treatment administration for patients with chronic iron overload

Jadenu (deferasirox), a new formulation of Exjade (deferasirox), is the only once-daily oral tablet for iron chelation Jadenu, taken with or without food, simplifies daily treatment administration...

FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma

Application Designed to Support Conversion of Accelerated to Full FDA Approval

THOUSAND OAKS, Calif., March

AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

WILMINGTON, Del., March 30, 2015 /PRNewswire/ -- Rigrodsky & Long, P.A.:

Lilly Announces Date for Diabetes Investor Meeting

INDIANAPOLIS, March 30, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a meeting on

Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference

THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Goldman S

Preparation Is Personal for Those with Chronic Illnesses

My Diabetes Emergency Plan helps patients with diabetes prepare for severe weather emergencies and unexpected predicaments

AUSTIN, Texas<

Background information from Pfizer on Lyrica pain patent and recent NHSE guidance

Background on second medical use patents Broadly speaking, a 'second medical use' patent is one that relates to a new medical use for aknown pharmaceutical or biological compound. They are...

Teva Reinforces Leadership Position in CNS with Acquisition of Auspex

Expected to strengthen Teva's core CNS franchise, establish Teva's leadership in underserved movement disorders space, provide compelling new treatment options for patients in need, and...

Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash

Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash Addition of RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid and BUPHENYL(R) (Sodium...

Johnson & Johnson to Webcast Annual Meeting of Shareholders

NEW BRUNSWICK, N.J., March 27, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will webcast its A

Orexigen's Mysimba™ Approved in Europe for the Treatment of Obesity

SAN DIEGO, March 26, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the European Commission has granted marketing authorization for Mysimba™ (naltrexone...

Novo Nordisk A/S : Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and Ryzodeg® in the US

Bagsværd, Denmark, 26 March 2015 - Novo Nordisk today announced that the company has decided to submit the prespecified interim analysis of DEVOTE as part of a Class II Resubmission of the New...

Genentech Announces Plans To Expand Hillsboro Facility

Investment To Bring Up to 100 New Jobs to the State South San Francisco, Calif. -- March 26, 2015 -- Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for...

Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer

THOUSAND OAKS, Calif., March 26, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that breast cancer

Sagent Pharmaceuticals Announces Leadership Changes

--Jeffrey Yordon Retires as Chairman and CEO; Board Member, Frank Kung, Ph.D. Appointed Chairman-- --Board Launches Search for Permanent CEO--...

GSK receives approval for Encruse® Ellipta® (umeclidinium) in Japan for the treatment of COPD

- Two further GSK products, Duac® Combination Gel and Synflorix™, also gain approval in Japan GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the Japanese Ministry of...